Orphan Drugs

CarthaGenetics® worked with Bayer Turkey to establish an interactive value demonstration tool in SPAF patients based on health economics and outcome researches.

It is the first time a pharmaceutical company conducts an interactive value demonstration tool for presenting the value of products to physicians in Turkey. We hope to see more creative and interactive examples in near future.

For any question concerning this, please contact our Market Access Team at kockaya@carthagenetics.comsharaf@carthagenetics.com or cavus@carthagenetics.com.